Regulation of feeding-associated peptides and receptors by nicotine

Molecular Neurobiology

Volumn 22, Issue 1-3, 2000, Pages 143-165

  Li, M D ^a   Parker, S L ^a   Kane, J K ^a  

^a UNIVERSITY OF TENNESSEE COLLEGE OF MEDICINE   (United States)

Author keywords

Body weight; Feeding; Leptin; Nicotine; NPY; Orexin; Receptor; Regulation; UCP

Indexed keywords

BRAIN PEPTIDE; LEPTIN; NEUROPEPTIDE; NEUROPEPTIDE Y; NICOTINE; NICOTINIC RECEPTOR; OREXIN; PEPTIDE HORMONE; UNCOUPLING PROTEIN;

ANIMAL CELL; ANIMAL MODEL; ARTICLE; BODY WEIGHT; CONTROLLED STUDY; ENERGY EXPENDITURE; FEEDING; FOOD INTAKE; HUMAN; HUMAN CELL; NEUROTRANSMISSION; NONHUMAN; PEPTIDE ANALYSIS; PROTEIN PROTEIN INTERACTION; RAT; RECEPTOR BINDING; SIGNAL TRANSDUCTION; SMOKING;

EID: 0034971238     PISSN: 08937648     EISSN: None     Source Type: Journal    
DOI: 10.1385/MN:22:1-3:143     Document Type: Article

References (179)

1. The role of nicotine in smoking-related cardiovascular disease
2. The peripheral vascular consequences of smoking
3. Clinical and pathophysiological effects of active and passive smoking on the cardiovascular system
4. Smoking and cardiovascular disease
5. Does nicotine have beneficial effects in the treatment of certain diseases?
6. Smoking and Alzheimer's disease: A review of the epidemiological evidence
7. Nicotine for Alzheimer's disease
8. The effects of nicotine on neural pathways implicated in depression: A factor in nicotine addiction?
9. Nicotine addiction
10. Addiction and schizophrenia
11. Cigarette smoking and major depression
12. Smoking, smoking withdrawal and schizophrenia: Case reports and a review of the literature
13. A review of the effects of nicotine on schizophrenia and antipsychotic medications
14. Willingness of female smokers to tolerate postcessation weight gain
15. Residence times and half-lives of nicotine metabolites in rat brain after acute peripheral administration of [2′-(14)C]nicotine
16. 3H]methylcarbamylcholine in rat brain
17. Biotransformation of primary nicotine metabolites. I. In vivo metabolism of R-(+)-[14C-NCH3]N-methylnicotinium ion in the guinea pig
18. Rapid and discrete changes in hypothalamic catecholamine nerve terminal systems induced by audiogenic stress, and their modulation by nicotine-relationship to neuroendocrine function
19. 3H]metabolites in rat striatum by nicotinic drugs
20. Presynaptic nicotinic receptors facilitate monoaminergic transmission
21. Postsynaptic nicotinic receptors on dopaminergic neurons in the substantia nigra pars compacta of the rat
22. Desensitization and resensitization of norepinephrine release in the rat hippocampus with repeated nicotine administration
23. Effect of chronic nicotine administration on monoamine and monoamine metabolite concentrations in rat brain
24. Persistent nicotinic blockade by chlorisondamine of noradrenergic neurons in rat brain and cultured PC12 cells
25. Regulation of neuropeptide release
26. The Ferrier Lecture, (1983). Amino acids and peptides: Fast and slow chemical signals in the nervous system?
27. Effects of nicotine on beta-endorphin, alpha MSH, and ACTH secretion by isolated perfused mouse brains and pituitary glands, in vitro
28. Nicotine stimulates the expression of cFos protein in the parvocellular paraventricular nucleus and brainstem catecholaminergic regions
29. Selective administration of nicotine into catecholaminergic regions of rat brainstem stimulates adrenocorticotropin secretion
30. Magnocellular neurons of the rat supraoptic nucleus are endowed with functional nicotinic acetylcholine receptors
31. Simultaneous and independent release of vasopressin and oxytocin in the rat
32. Ultrastructural changes in the neural lobe of the rat pituitary following nicotine pretreatment
33. Stimulation by nicotine of enteric inhibitory nerves and release of vasoactive intestinal peptide in the taenia of the guinea-pig caecum
34. Cholinergic regulation of vasoactive intestinal peptide content and release in rat frontal cortex and hippocampus
35. Insulin and glucagon secretion by ganglionic nicotinic activation in adrenalectomized mice
36. Involvement of cholinergic nicotine-like receptors as modulators of amine turnover in various types of hypothalamic dopamine and noradrenaline nerve terminal systems and of prolactin, LH, FSH and TSH secretion in the castrated male rat
37. Intravenous injections of nicotine induce very rapid and discrete reductions of hypothalamic catecholamine levels associated with increases of ACTH, vasopressin and prolactin secretion
38. Neuroendocrine actions of nicotine and of exposure to cigarette smoke: Medical implications
39. Toward a structural basis for the function of nicotinic acetylcholine receptors and their cousins
40. Acetylcholine receptor binding site contains a disulfide cross-link between adjacent half-cystinyl residues
41. Brain nicotinic receptors: Structure and regulation, role in learning and reinforcement
42. Diversity of nicotinic acetylcholine receptors in rat hippocampal neurons. I. Pharmacological and functional evidence for distinct structural subtypes
43. Identification of four classes of brain nicotinic receptors using beta2 mutant mice
44. Neuronal alpha-bungarotoxin receptors are alpha7 subunit homomers
45. The alpha7 nicotinic acetylcholine receptor in neuronal plasticity
46. Neuronal nicotinic receptors: Molecular organization and regulations
47. Nicotinic receptors in the brain. Molecular biology, function, and therapeutics
48. A prospective study of the effects of changes in smoking habits on blood count, serum lipids and lipoproteins, body weight and blood pressure in occupationally active men. The Israeli CORDIS Study
49. Body habitus changes among adult males from the normative aging study: Relations to aging, smoking history and alcohol intake
50. Smoking cessation and severity of weight gain in a national cohort
51. Weight change after smoking cessation in general practice
52. Women gain weight 1 year after smoking cessation while dietary intake temporarily increases
53. Can physical activity minimize weight gain in women after smoking cessation?
54. Characteristics associated with excessive weight gain after smoking cessation in men
55. Smoking cessation and weight gain
56. Nicotine administration enhances NPY expression in the rat hypothalamus
57. Nicotine's effects on female rats' body weight: Caloric intake and physical activity
58. Nicotine administration reduces neuropeptide Y and neuropeptide Y mRNA concentrations in the rat hypothalamus: NPY may mediate nicotine's effects on energy balance
59. Effects of nicotine on body weight and food consumption in female rats
60. Increased 24-hour energy expenditure in cigarette smokers
61. The effect of nicotine on energy expenditure during light physical activity
62. Alterations of lipolysis and lipoprotein lipase in chronically nicotine-treated rats
63. Positional cloning of the mouse obese gene and its human homologue
64. Isolation and characterization of peptide YY (PYY), a candidate gut hormone that inhibits pancreatic exocrine secretion
65. Orexins and orexin receptors: A family of hypothalamic neuropeptides and G protein-coupled receptors that regulate feeding behavior
66. The hypocretins: Hypothalamus-specific peptides with neuroexcitatory activity
67. Role of melanocortinergic neurons in feeding and the agouti obesity syndrome
68. Targeted disruption of the melanocortin-4 receptor results in obesity in mice
69. PCR differential display identifies a rat brain mRNA that is transcriptionally regulated by cocaine and amphetamine
70. Hypothalamic CART is a new anorectic peptide regulated by leptin
71. Synergistic interaction between leptin and cholecystokinin to reduce short-term food intake in lean mice
72. Neuropeptide regulation of appetite and weight
73. Leptin increases uncoupling protein expression and energy expenditure
74. UCP2, UCP3 and leptin gene expression: Modulation by food restriction and leptin
75. Unraveling the central nervous system pathways underlying responses to leptin
76. Energy homeostasis and body weight
77. Identification and expression cloning of a leptin receptor, OB-R
78. The long form of the leptin receptor (OB-Rb) is widely expressed in the human brain
79. Role of leptin in the neuroendocrine response to fasting
80. Identification of targets of leptin action in rat hypothalamus
81. The role of neuropeptide Y in the antiobesity action of the obese gene product
82. Anatomic localization of alternatively spliced leptin receptors (Ob-R) in mouse brain and other tissues
83. Weight-reducing effects of the plasma protein encoded by the obese gene
84. Decreased food intake does not completely account for adiposity reduction after ob protein infusion
85. Effects of the obese gene product on body weight regulation in ob/ob mice
86. Role of leptin in fat regulation
87. Is leptin sensitivity the link between smoking cessation and weight gain?
88. Serum leptin levels in Mexican Americans and non-Hispanic whites: Association with body mass index and cigarette smoking
89. Effect of birth weight and maternal smoking on cord blood leptin concentrations of full-term and preterm newborns
90. Leptin levels in smokers and long-term users of nicotine gum
91. Plasma leptin concentrations and lipid profiles during nicotine abstinence
92. Effects of nicotine on the expression of plasma leptin and its receptor mRNA in rat
93. Mechanisms responsible for sympathetic activation by cigarette smoking in humans
94. Metabolic interactions between surplus dietary energy intake and cigarette smoking or its cessation
95. Fatty acid circuit as a physiological mechanism of uncoupling of oxidative phosphorylation
96. On the mechanism of fatty acid-induced proton transport by mitochondrial uncoupling protein
97. Photoactivated azido fatty acid irreversibly inhibits anion and proton transport through the mitochondrial uncoupling protein
98. Molecular approach to thermogenesis in brown adipose tissue: cDNA cloning of the mitochondrial uncoupling protein
99. Mitochondrial uncoupling protein from mouse brown fat. Molecular cloning, genetic mapping, and mRNA expression
100. Regulation of the uncoupling protein gene expression
101. Uncoupling protein-3: A new member of the mitochondrial carrier family with tissue-specific expression
102. Uncoupling protein-2: A novel gene linked to obesity and hyperinsulinemia
103. UCP3: An uncoupling protein homologue expressed preferentially and abundantly in skeletal muscle and brown adipose tissue
104. Abnormal splicing of the leptin receptor in diabetic mice
105. Nicotine increases thermogenesis in brown adipose tissue in rats
106. Nicotine induces uncoupling protein I in white adipose tissue of obese mice
107. Neuropeptide Y distribution in the rat brain
108. Neuropeptide Y-related peptides and their receptors are the receptors potential therapeutic drug targets?
109. Multiple receptors for the pancreatic polypeptide (PP-fold) family: Physiological implications
110. Age-related bidirectional changes in neuropeptide Y peptides in rat adrenal glands, brain, and blood
111. Nonsaturable entry of neuropeptide Y into brain
112. Mechanisms of interaction of peptide and nonpeptide vascular neurotransmitter systems
113. Neuropeptide Y: Intraaccumbens injections produce a place preference that is blocked by cis-flupenthixol
114. Receptors controlling transmitter release from sympathetic neurons in vitro
115. Inhibitory effects of neuropeptide Y on cyclic AMP accumulation in slices of the nucleus tractus solitarius region of the rat
116. Neuropeptide Y receptors and the inhibition of adenylate cyclase in the human frontal and temporal cortex
117. Characterization of Y1, Y2 and Y5 subtypes of neuropeptide Y (NPY) receptor in rabbit kidney
118. Characterization of rabbit kidney and brain pancreatic polypeptide- binding neuropeptide Y receptors: Differences with Y1 and Y2 sites in sensitivity to amiloride derivatives affecting sodium transport
119. Altered expression of hypothalamic neuropeptide mRNAs in food-restricted and food-deprived rats
120. Nicotine elicits changes in expression of adrenal catecholamine biosynthetic enzymes, neuropeptide Y and immediate early genes by injection but not continuous administration
121. Structure-function analysis of stimulation of food intake by neuropeptide Y: Effects of receptor agonists
122. Evidence for neuropeptide Y mediation of eating produced by food deprivation and for a variant of the Y1 receptor mediating this peptide's effect
123. A receptor subtype involved in neuropeptide-Y-induced food intake
124. Food intake in free-feeding and energy-deprived lean rats is mediated by the neuropeptide Y5 receptor
125. Inhibition of neuropeptide Y (NPY)-induced feeding and c-Fos response in magnocellular paraventricular nucleus by a NPY receptor antagonist: A site of NPY action
126. Role of the Y1 receptor in the regulation of neuropeptide Y-mediated feeding: Comparison of wild-type, Y1 receptor-deficient, and Y5 receptor-deficient mice
127. The pharmacology of neuropeptide Y (NPY) receptor-mediated feeding in rats characterizes better Y5 than Y1, but not Y2 or Y4 subtypes
128. Characterization of the neuropeptide Y5 receptor in the human hypothalamus: A lack of correlation between Y5 mRNA levels and binding sites
129. Agonist regulation of cellular Gs alpha-subunit levels in neuroblastoma x glioma hybrid NG108-15 cells transfected to express different levels of the human beta 2 adrenoceptor
130. Agonist-mediated downregulation of G alpha i via the alpha 2-adrenergic receptor is targeted by receptor-Gi interaction and is independent of receptor signaling and regulation
131. Tertiary and quaternary structural changes in Gi alpha 1 induced by GTP hydrolysis
132. Activation of phospholipase C by heat shock requires GTP analogs and is resistant to pertussis toxin
133. Orexin A-like immunoreactivity in the rat brain
134. Differential distribution of orexin-A and orexin-B immunoreactivity in the rat brain and spinal cord
135. Distribution of orexin-A and orexin-B (hypocretins) in the rat spinal cord
136. Distribution of orexin/hypocretin in the rat median eminence and pituitary
137. Widespread distribution of orexin in rat brain and its regulation upon fasting
138. Distribution of orexin neurons in the adult rat brain
139. Neurons containing hypocretin (orexin) project to multiple neuronal systems
140. Distribution and quantification of immunoreactive orexin A in rat tissues
141. Diurnal variation in orexin A immunoreactivity and preproorexin mRNA in the rat central nervous system
142. Food intake elicited by central administration of orexins/hypocretins: Identification of hypothalamic sites of action
143. Independent feeding and metabolic actions of orexins in mice
144. Narcolepsy in orexin knockout mice: Molecular genetics of sleep regulation
145. The sleep disorder canine narcolepsy is caused by a mutation in the hypocretin (orexin) receptor 2 gene
146. The hypocretin/orexin ligand-receptor system: Implications for sleep and sleep disorders
147. Role of orexins in sleep and arousal mechanisms
148. Hypothalamic hypocretin (orexin): Robust innervation of the spinal cord
149. Pressor effects of orexins injected intracisternally and to rostral ventrolateral medulla of anesthetized rats
150. Sympathetic and cardiovascular actions of orexins in conscious rats
151. Possible involvement of orexin in the stress reaction in rats
152. Centrally administered orexin/hypocretin activates HPA axis in rats
153. Orexins and orexin receptors: Implication in feeding behavior
154. Nicotine upregulates expression of orexin and its receptors in rat brain
155. Chronic nicotine administration differentially affects neurotransmitter release from rat striatal slices
156. Nicotine increases stress-induced serotonin release by stimulating nicotinic acetylcholine receptor in rat striatum
157. Sensitivity of orexin-A binding to phospholipase C inhibitors, neuropeptide Y, and secretin
158. Regulation of pituitary receptors for gonadotropin-releasing hormone during the rat estrous cycle
159. Influence of the cytosolic carboxyl termini of human B1 and B2 kinin receptors on receptor sequestration, ligand internalization, and signal transduction
160. Identification of a cytoplasmic Ser-Thr-Leu motif that determines agonist-induced internalization of the AT1 angiotensin receptor
161. Orexin A but not orexin B rapidly enters brain from blood by simple diffusion
162. Microdialysis studies of brain norepinephrine, serotonin, and dopamine release during ingestive behavior. Theoretical and clinical implications
163. Brain monoamines and peptides: Role in the control of eating behavior
164. Brain serotonin and eating behavior
165. Analysis of feeding suppression produced by perifornical hypothalamic injection of catecholamines, amphetamines and mazindol
166. Increased food intake, body weight, and adiposity in rats after regional neurochemical depletion of serotonin
167. Catecholaminergic mechanisms of the lateral hypothalamus: Their role in the mediation of amphetamine anorexia
168. Amphetamine: Effects on meal patterns and macronutrient selection
169. Food reward and cocaine increase extracellular dopamine in the nucleus accumbens as measured by microdialysis
170. Feeding and hypothalamic stimulation increase dopamine turnover in the accumbens
171. Feeding increases extracellular serotonin in the lateral hypothalamus of the rat as measured by microdialysis
172. Serotonin release in lateral and medial hypothalamus during feeding and its anticipation
173. Nucleus accumbens dopamine depletions make rats more sensitive to high ratio requirements but do not impair primary food reinforcement
174. Scheduled eating increases dopamine release in the nucleus accumbens of food-deprived rats as assessed with on-line brain dialysis
175. Ventrolateral striatal dopamine depletions impair feeding and food handling in rats
176. Nucleus accumbens dopamine release increases during instrumental level pressing for food but not free food consumption
177. Nicotine's effect on hypothalamic neurotransmitters and appetite regulation
178. Infusion of nicotine into the LHA enhances dopamine and 5-HT release and suppresses food intake